Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 5
2005 2
2006 1
2007 6
2009 6
2010 5
2011 3
2012 2
2013 7
2014 3
2015 3
2016 7
2019 2
2020 3
2021 2
2022 4
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Adjustment for continuous confounders: an example of how to prevent residual confounding.
Groenwold RH, Klungel OH, Altman DG, van der Graaf Y, Hoes AW, Moons KG; PROTECT WP2 (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium, Work Programme 2 [Framework for pharmacoepidemiology studies]). Groenwold RH, et al. CMAJ. 2013 Mar 19;185(5):401-6. doi: 10.1503/cmaj.120592. Epub 2013 Feb 11. CMAJ. 2013. PMID: 23401401 Free PMC article. Review. No abstract available.
Eicosanoids in the innate immune response: TLR and non-TLR routes.
Alvarez Y, Valera I, Municio C, Hugo E, Padrón F, Blanco L, Rodríguez M, Fernández N, Crespo MS. Alvarez Y, et al. Mediators Inflamm. 2010;2010:201929. doi: 10.1155/2010/201929. Epub 2010 Jun 15. Mediators Inflamm. 2010. PMID: 20689730 Free PMC article. Review.
Discovery and Development of the Quininib Series of Ocular Drugs.
Mahon N, Slater K, O'Brien J, Alvarez Y, Reynolds A, Kennedy B. Mahon N, et al. Among authors: alvarez y. J Ocul Pharmacol Ther. 2022 Jan-Feb;38(1):33-42. doi: 10.1089/jop.2021.0074. J Ocul Pharmacol Ther. 2022. PMID: 35089801
NeuroEPO plus (NeuralCIM®) in mild-to-moderate Alzheimer's clinical syndrome: the ATHENEA randomized clinical trial.
Sosa S, Bringas G, Urrutia N, Peñalver AI, López D, González E, Fernández A, Hernández ZM, Viña A, Peña Y, Batista JF, Valenzuela C, León K, Crombet T, Rodríguez T, Pérez L; ATHENEA Investigators. Sosa S, et al. Alzheimers Res Ther. 2023 Dec 13;15(1):215. doi: 10.1186/s13195-023-01356-w. Alzheimers Res Ther. 2023. PMID: 38093366 Free PMC article. Clinical Trial.
Oleanolic acid ameliorates intestinal alterations associated with EAE.
Gutierrez B, Gallardo I, Ruiz L, Alvarez Y, Cachofeiro V, Margolles A, Hernandez M, Nieto ML. Gutierrez B, et al. Among authors: alvarez y. J Neuroinflammation. 2020 Nov 27;17(1):363. doi: 10.1186/s12974-020-02042-6. J Neuroinflammation. 2020. PMID: 33246492 Free PMC article.
61 results